Literature DB >> 32188773

Underweight Increases the Risk of End-Stage Renal Diseases for Type 2 Diabetes in Korean Population: Data From the National Health Insurance Service Health Checkups 2009-2017.

Yang-Hyun Kim1, Jun Goo Kang2, Seong Jin Lee3, Kyung-do Han4, Sung-Hee Ihm3, Kyung-Hwan Cho1, Yong-Gyu Park4.   

Abstract

OBJECTIVE: There is a controversy over the association between obesity and end-stage renal disease (ESRD) in people with or without type 2 diabetes; therefore, we examined the effect of BMI on the risk of ESRD according to glycemic status in the Korean population. RESEARCH DESIGN AND METHODS: The study monitored 9,969,848 participants who underwent a National Health Insurance Service health checkup in 2009 from baseline to the date of diagnosis of ESRD during a follow-up period of ∼8.2 years. Obesity was categorized by World Health Organization recommendations for Asian populations, and glycemic status was categorized into the following five groups: normal, impaired fasting glucose (IFG), newly diagnosed diabetes, diabetes <5 years, and diabetes ≥5 years.
RESULTS: Underweight was associated with a higher risk of ESRD in all participants after adjustment for all covariates. In the groups with IFG, newly diagnosed type 2 diabetes, diabetes duration <5 years, and diabetes ≥5 years, the hazard ratio (HR) of the underweight group increased with worsening glycemic status (HR 1.431 for IFG, 2.114 for newly diagnosed diabetes, 4.351 for diabetes <5 years, and 6.397 for diabetes ≥5 years), using normal weight with normal fasting glucose as a reference. The adjusted HRs for ESRD were also the highest in the sustained underweight group regardless of the presence of type 2 diabetes (HR 1.606 for nondiabetes and 2.14 for diabetes).
CONCLUSIONS: Underweight showed more increased HR of ESRD according to glycemic status and diabetes duration in the Korean population. These associations also persisted in the group with sustained BMI during the study period.
© 2020 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32188773     DOI: 10.2337/dc19-2095

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  4 in total

1.  The risk of consequent nephropathy following initial weight loss in diabetic patients treated with sodium glucose cotransporter 2 inhibitors.

Authors:  Yi-Hsin Chan; Shao-Wei Chen; Tze-Fan Chao; Yi-Wei Kao; Chien-Ying Huang; Pao-Hsien Chu
Journal:  Cardiovasc Diabetol       Date:  2021-08-16       Impact factor: 9.951

2.  Characterization of Medication Trends for Chronic Kidney Disease: Mineral and Bone Disorder Treatment Using Electronic Health Record-Based Common Data Model.

Authors:  Sungdam Han; Minkook Son; Byungjin Choi; ChulHyoung Park; Dong Ho Shin; Jong Hwan Jung; Min-Jeong Lee; Gyu-Tae Shin; Heungsoo Kim; Rae Woong Park; Inwhee Park
Journal:  Biomed Res Int       Date:  2021-11-22       Impact factor: 3.411

3.  Health Behaviors of Austrian Secondary School Teachers and Principals at a Glance: First Results of the From Science 2 School Study Focusing on Sports Linked to Mixed, Vegetarian, and Vegan Diets.

Authors:  Katharina C Wirnitzer; Clemens Drenowatz; Armando Cocca; Derrick R Tanous; Mohamad Motevalli; Gerold Wirnitzer; Manuel Schätzer; Gerhard Ruedl; Werner Kirschner
Journal:  Nutrients       Date:  2022-03-03       Impact factor: 5.717

4.  Prediction Model for Hypertension and Diabetes Mellitus Using Korean Public Health Examination Data (2002-2017).

Authors:  Yong Whi Jeong; Yeojin Jung; Hoyeon Jeong; Ji Hye Huh; Ki-Chul Sung; Jeong-Hun Shin; Hyeon Chang Kim; Jang Young Kim; Dae Ryong Kang
Journal:  Diagnostics (Basel)       Date:  2022-08-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.